Head and Neck Squamous Cell Carcinoma
Conditions
Interventions
Group 1: Retrospective data collection and study. All patients who underwent neck dissection at the Department of Otorhinolaryngology (ENT) between 2017 and 2025 will be included in the study. We expe
Sponsors
Universitätsklinikum Mannheim
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who underwent neck dissection as part of the treatment for head and neck cancer at University Medical Center Mannheim between 2017 and 2025.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measures: Cervical lymph node (N) status as assessed by ultrasonography, computed tomography, and histopathological examination. Data will be collected retrospectively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures: Extranodal extension (ENE) and HPV status. | — |
Countries
Germany
Contacts
Public ContactLena Huber
Universitätsklinikum Mannheim
Outcome results
None listed